Healthcare -
Biotechnology - NASDAQ - US
$ 18.05
2.67 %
$ 1.24 B
Market Cap
-3.77
P/E
ARVN - SHORT-TERM DEBT
Short-term Debt ARVN - Arvinas, Inc.
1.9 M
LAST VALUE
-7.07%
2 YEAR CAGR
65.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR